Lattice Biologics Ltd. Announces Completion of Transaction to Reduce Royalty and Debt Obligations
SCOTTSDALE, AZ--(Marketwired - June 13, 2017) - Lattice Biologics Ltd. (TSX VENTURE: LBL) (OTCQB: LBLTF) ("Lattice Biologics" or the "Company") announced today that it has completed the previously announced transaction to significantly reduce the Company's royalty and debt obligations (the "Transaction") with Grenville Royalty Corp. ("Grenville").